Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 1

Status

Recruiting 4Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 5Gynecologic 1

Conditions

Breast Neoplasms 4Triple Negative Breast Neoplasms 1Ovarian Neoplasms 1Metastatic Breast Cancer With a Isolated Brain Progression 1

Interventions

pembrolizumab 603Cyclophosphamide 545Magnetic Resonance Spectroscopy 527Radiotherapy 513Specimen Handling 505Nivolumab 411Cisplatin 381Carboplatin 369Biopsy 305Blood Specimen Collection 304Radiosurgery 290Paclitaxel 281Gemcitabine 271Surveys and Questionnaires 269Standard of Care 267fludarabine 263Drug Therapy 263Dexamethasone 263Bevacizumab 252venetoclax 251Oxaliplatin 209Capecitabine 199Rituximab 198Radiation 191Ipilimumab 188Fluorouracil 188durvalumab 185Doxorubicin 178Etoposide 177atezolizumab 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Biosimilar Pharmaceuticals × 1 year × Clear all
NCT07220135 2026-05-06

NeoTHERa

University of Kansas Medical Center

Phase 2 Recruiting
100 enrolled
Breast

Breast Neoplasms

NCT06649331 2026-04-08

Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer

Fudan University

Phase 2 Recruiting
160 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07393425 2026-02-06

Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast Cancer

Shanghai Jiao Tong University School of Medicine

Phase 2 Recruiting
50 enrolled
Breast

Breast Neoplasms

NCT07246317 2025-11-28

Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Not yet recruiting
188 enrolled
Breast

Breast Neoplasms

NCT05041842 2025-11-17

InTTercePT

UNICANCER

Phase 2 Active not recruiting
53 enrolled
Breast

Metastatic Breast Cancer With a Isolated Brain Progression

NCT06292286 2025-06-11

SCENIC

The University of Hong Kong

Phase NA Recruiting
18 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡